Prime Medicine
PRME
PRME
115 hedge funds and large institutions have $467M invested in Prime Medicine in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.33% more ownership
Funds ownership: 50.25% → 55.58% (+5.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less call options, than puts
Call options by funds: $407K | Put options by funds: $489K
Holders
115
Holding in Top 10
2
Calls
$407K
Puts
$489K
Top Buyers
| 1 | +$22.4M | |
| 2 | +$21.6M | |
| 3 | +$20M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$13.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.2M |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$1.08M | |
| 3 | -$1.08M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.06M |
| 5 |
Walleye Capital
New York
|
-$405K |